Policy / Pricing Eli Lilly issues data sharing ultimatum to 340B hospitals BioPharma DiveSelect hospitals have refused to share data to prove they re not double-dipping drug discounts, Lilly said.Read full story pharminent June 2, 2026 (Last updated: June 3, 2026) BioPharma Dive Select hospitals have refused to share data to prove they re not double-dipping drug discounts, Lilly said. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Fulcrum exploring a potential sale after FDA sidelined its sickle cell drugNext: ASCO26: In vivo CAR-Ts in the spotlight Related Stories Policy / Pricing US generic tariff reprieve on the rocks as Trump proposes 100% rate in 2028 pharminent July 22, 2026 Policy / Pricing UK commits to pharma IP protection in Swiss trade deal pharminent July 16, 2026 Policy / Pricing Germany approves healthcare costs overhaul despite significant pharma opposition pharminent July 13, 2026
